Joshua Samek

JOSHUA SAMEK focuses his practice on mergers and acquisitions, capital markets and financing transactions, and general corporate and securities matters. He has extensive experience advising private equity funds and their portfolio companies, public companies, and founders across a wide range of industries, with a concentration on the healthcare, technology, and life sciences sectors. He also acts for public company boards of directors and executive management on U.S. Securities and Exchange Commission reporting and corporate governance matters.

Advocacy on behalf of his clients has earned Josh awards and acknowledgement in industry publications, including:

• Chambers USA, South Florida Corporate/M&A & Private Equity (2021–2025)
• The Best Lawyers in America®, Securities/Capital Markets Law (2026)
• Legal 500 United States, Healthcare: Service Providers (2022–2023)
• Legal 500 United States, Fintech (2020)
• IFLR1000, Notable Practitioner, Private Equity; M&A (2020)
• IFLR1000 United States, Capital Markets (2018)
• Daily Business Review, “Most Effective Lawyer – Corporate Securities” (2019)

Prior to joining Sidley, Josh was a partner at another global law firm, where he served as chair of the Florida Corporate practice. 

Capital Markets

• A NYSE-listed provider of physician services in its private offerings of unsecured senior notes under Rule 144A. 
• A Nasdaq-listed women’s healthcare company in its public offerings and at-the-market offerings of common stock, as well as preferred and common stock PIPE financing. 
• A Nasdaq-listed diversified healthcare company in its public offering of convertible notes. 

Mergers and Acquisitions

• A fintech platform in its business combination with an NYSE-listed special purpose acquisition company.
• A technology-enabled provider of value-based healthcare in its business combination with a Nasdaq-listed special purpose acquisition company.
• A Nasdaq-listed technology-enabled provider of value-based healthcare in its acquisition of the value-based Medicare business of a leading hospital system.
• A Nasdaq-listed women’s healthcare company in the exclusive licensing of its pharmaceutical products.
• A private-equity-backed technology company in the divestiture of its data analytics platform.
• A private-equity-backed technology company in the acquisition of a CX design, transformation, and BPO services platform.
• A private-equity-backed provider of supply chain automation and logistics software in its recapitalization by a global private equity firm.
• A Nasdaq-listed special purpose acquisition company in its business combination with an Australian Stock Exchange-listed technology company.
• A NYSE-listed provider of physician services in the divestiture of its radiology and AI-assisted teleradiology business.
• A NYSE-listed provider of physician services in the divestiture of its anesthesiology business.
• A Nasdaq-listed multinational biopharmaceutical and diagnostics company in its acquisition of a Nasdaq-listed diagnostic laboratory company.
• A Nasdaq-listed multinational biopharmaceutical and diagnostics company in its acquisition of a Nasdaq-listed biopharmaceutical development company.
• A private-equity-backed technology-enabled provider of health system performance optimization solutions in its sale to a new sponsor.
• A private-equity-backed professional employer organization in a management buyout backed by a new sponsor.
• An insuretech company in the concurrent disposition of its technology assets and business-to-business insurance agency.
• An insuretech company in its acquisition of a business-to-business insurance agency from a global insurance broker and associated debt and equity financing.

Debt Financings

• A NYSE-listed provider of physician services in its unsecured revolving credit facilities and term loans.
• A fintech platform in multiple credit facilities, warehouse facilities, and other structured financing arrangements.
• A Nasdaq-listed technology-enabled provider of value-based healthcare in its senior secured and structured credit facilities.
• An insuretech company in its senior and subordinated credit facilities. 
• A Nasdaq-listed women’s healthcare company in its senior secured credit facilities.
• A private-equity-sponsored business process outsourcing company in numerous secured revolving credit facilities and term loans.

Venture Capital/Minority Investments/Joint Ventures

• A non-profit organization in connection with more than 40 venture capital investment transactions. 
• An insuretech company in a highly structured minority investment.
• An insuretech company in a joint venture and technology licensing transaction.
• A technology-based education company in capital raising and debt financing transactions.

Some of the above matters were handled prior to joining Sidley. 

• Board of Directors, Miami-Dade Beacon Council
• Board of Directors, University of Miami Hillel
• Member, Greater Miami Jewish Federation Planning and Distribution Committee
• Northwestern University Kellogg School of Management, Executive Leadership Program Certification, 2024
• Past Member, Advisory Board, National Association of Corporate Directors, Florida Chapter
  
• Past Member, Board of Trustees, The Leukemia & Lymphoma Society, Southern Florida Chapter
• Past Chair, Florida Advocacy Committee, The Leukemia & Lymphoma Society, Southern Florida Chapter
• Member, American Bar Association